The lads talked to Dr Elena Tsourdi about personalised care for osteoporosis patients. Elena is working as the Senior Consultant at the Department for Metabolic Bone Diseases, with a focus on secondary osteoporosis and rare bone diseases. We had a fascinating chat about how doctors and patients can build trust and prescribe medicines to get the best outcomes for individual patients.

The lads talked to Professor Roland Baron from Harvard University. Roland has played a key role in characterising bone signalling pathways that govern bone formation and contributed to developing new treatments that increase cell signalling to improve bone mass.

Roland is a co-founder and chair of the International Federation of Musculoskeletal Research Societies supporting our community and helping young scientists from the entire world to develop and support people living with osteoporosis.

The lads talked to each other about the exciting news that the National Institute for Health and Care Excellence (Nice) announced it had approved a new drug, Abaloparatide, for use by the health service. It will be available for use on the NHS in England within three months.

The lads talk to Dr Friederike Schulte about exciting research which shows that mechanical loading potentiates the effect of anabolic treatments for osteoporosis, leading to bigger gains in bone mass and strength. Friederike also spoke to us about her role in public outreach as a Co-Founder at the Swiss Fall Prevention Center. The startup works in the community to share knowledge about fall prevention with people at risk of a fracture, including expert lectures in senior and residential homes.

The lads jetted off to sunny Marseille in the South of France to get you updates on the latest bone research. We talked to Federico Moscogiuri, Ralph Muller and Aline Bozec from the IFMRS about supporting global musculoskeletal research. We also chatted with Annegreet Vlug and Petar Milovanovic from the ECTS academy about their research and supporting young scientists.

The IFMRS Online Learning Environment (HubLE) provides high-quality, accessible knowledge about MSK research, with an emphasis on innovation, enabling early investigators to learn, share and network with each other and with professionals from across the world.

The lads jetted off to sunny Marseille in the South of France to get you updates on the latest bone research. We talked to Thomas Funck-Brentano about highlights from last year and spoke to some of the young prize winners. We also chatted with Jeroen Geurts and Alex Ireland from the ECTS academy about their research and supporting young scientists.

(https://ects-academy.org/)

The lads talked to Dr. Madhavi Vindlacheruvu about frailty and osteoporosis. We discussed what frailty is and how it can be diagnosed, as well as the patient-centred care developed and practiced by the teams at Addenbrookes Hospital in Cambridge. Pre- and post-fracture care is more complex than you would think in geriatric patients. Dr Madhavi is a consultant orthogeriatrican at Addenbrookes Hospital in Cambridge and Clinical lead for National Hip Fracture Database, and the Fracture Liaison Services at the trust

The lads talk to Dr Jennie Walsh about bone health in teenager years and young adults. We discussed how doctors asses and treat low bone density in young people. We also talked about the effect of eating disorders on bone health. Dr Walsh is a Senior Clinical Lecturer in the Metabolic Bone Centre at the University of Sheffield.